Personalized support and partnership you can trust             Welcome JOHN, Thank you for registering with www.copaxone.com. Please take a minute to review the personal information you shared with us by visiting My Profile. You can update your information and preferences there at any time. We’ll be updating www.copaxone.com often with relevant and important information, so be sure to visit it regularly. Out goal is to serve the relapsing MS community by offering online what we have been delivering offline for over 10 years: support, knowledge, and answers. Again, a big welcome and thank you. We look forward to hearing from you online, offline, anytime.   For support or additional information, please call Shared Solutions® at 1-800-887-8100, or visit www.copaxone.com.     Now you have access to all the great support you’ve come to expect from Shared Solutions®, plus: Access to all the tools and resources on www.copaxone.com for help managing your therapy routine Online reservations to attend live educational events in your area Updates about relapsing MS management and MS community news 24/7 phone access to MS-certified nurses Plus, all the other great ways Shared Solutions® can support you throughout your therapy experience.           COPAXONE® (glatiramer acetate injection) is indicated for the treatment of patients with relapsing forms of multiple sclerosis. Important Safety Information Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again. Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense. A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes. The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information.       Privacy Policy | One-click Unsubscribe | Terms of Use   COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. © 2014 Teva Neuroscience, Inc. COP-41320 Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211